Cargando…

CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ

Clinical treatment outcome of MRONJ (medication-related osteonecrosis of the jaw) surgery despite radical osseous removal and primary closure healing still shows differences in terms of outcome and disease recurrence. The study aims to assess the rate of angiogenesis of MRONJ lesions in order to und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcianò, Antonia, Ieni, Antonio, Mauceri, Rodolfo, Oteri, Giacomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582901/ https://www.ncbi.nlm.nih.gov/pubmed/34769880 http://dx.doi.org/10.3390/ijerph182111362

Ejemplares similares

Oral Surgical Management of Bone and Soft Tissues in MRONJ Treatment: A Decisional Tree
por: Marcianò, Antonia, et al.
Publicado: (2020)

Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105
por: Kataria, Sant Prakash, et al.
Publicado: (2021)

Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma
por: Marioni, Gino, et al.
Publicado: (2020)

MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series
por: Mauceri, Rodolfo, et al.
Publicado: (2023)

Evaluation of microvessel density with CD31 and CD105 in patients with psoriasis under methotrexate and acitretin therapy
por: Zemheri, Ebru, et al.
Publicado: (2020)

Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy
por: Miyata, Yasuyoshi, et al.
Publicado: (2015)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
por: Campisi, Giuseppina, et al.
Publicado: (2020)

Endoglin (CD105) is a more appropriate marker than CD31 for detecting microvessels in carotid artery plaques
por: Fukumitsu, Ryu, et al.
Publicado: (2013)

Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis
por: Li, C, et al.
Publicado: (2003)

Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset
por: Marcianò, Antonia, et al.
Publicado: (2021)

An Immunohistochemical Survey to Evaluate the Expression of CD105 and CD34 in Ameloblastoma and Odontogenic Keratocyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2014)

Immunohistochemical Comparison of the Expression of CD34 and CD105 in Odontogenic Keratocyst and Dentigerous Cyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2017)

Reply to Fusco et al. Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors? A Word of Cautiousness. Comment on “Marcianò et al. Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association. Int. J. Environ. Res. Public Health 2020, 17, 9509”
por: Marcianò, Antonia, et al.
Publicado: (2021)

Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton’s Jelly
por: Walecka, Irena, et al.
Publicado: (2017)

A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis
por: Campisi, Giuseppina, et al.
Publicado: (2021)

Tortuous Microvessels Contribute to Wound Healing via Sprouting Angiogenesis
por: Chong, Diana C., et al.
Publicado: (2017)

VEGF and CD 34: A correlation between tumor angiogenesis and microvessel density-an immunohistochemical study
por: Kukreja, Ipsita, et al.
Publicado: (2013)

Quantitative evaluation of microvessel density using CD34 in clinical variants of ameloblastoma: An immunohistochemical study
por: Pereira, Treville, et al.
Publicado: (2016)

Expression and clinical significance of CD31, CD34, and CD105 in pulmonary ground glass nodules with different vascular manifestations on CT
por: Guo, Chen-ran, et al.
Publicado: (2022)

The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists
por: Mauceri, Rodolfo, et al.
Publicado: (2022)

Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression
por: Paschoal, Juliana Passos, et al.
Publicado: (2014)

CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34
por: Miyata, Yasuyoshi, et al.
Publicado: (2013)

Human Cardiac Mesenchymal Stromal Cells with CD105(+)CD34(-) Phenotype Enhance the Function of Post-Infarction Heart in Mice
por: Czapla, Justyna, et al.
Publicado: (2016)

MiR-665 aggravates heart failure via suppressing CD34-mediated coronary microvessel angiogenesis
por: Fan, Jiahui, et al.
Publicado: (2018)

A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion
por: Miao, Yanming, et al.
Publicado: (2016)

Nanofiber-expanded human CD34(+) cells heal cutaneous wounds in streptozotocin-induced diabetic mice
por: Kanji, Suman, et al.
Publicado: (2019)

Reproducibility of microvessel counts in breast cancer specimens
por: Marson, L P, et al.
Publicado: (1999)

Evaluation of Mast Cell Density using CD117 antibody and Microvessel Density Using CD34 Antibody in Different Grades of Oral Squamous Cell Carcinoma
por: Ansari, Fakeha Meraj, et al.
Publicado: (2020)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer
por: Wang, Wen-Quan, et al.
Publicado: (2013)

CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
por: Martinez, Leandro Marcelo, et al.
Publicado: (2015)

CD105(+)CD90(+)CD13(+) identifies a clonogenic subset of adventitial lung fibroblasts
por: Kadefors, Måns, et al.
Publicado: (2021)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Correction: CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
Publicado: (2015)

MRONJ and COVID-19 caution
por: Hasan, A., et al.
Publicado: (2021)

The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols
por: Di Fede, Olga, et al.
Publicado: (2021)

Ninjurin1 Deletion in NG2-Positive Pericytes Prevents Microvessel Maturation and Delays Wound Healing
por: Matsuo, Risa, et al.
Publicado: (2022)

Quality‐Quantity Control Culture Enhances Vasculogenesis and Wound Healing Efficacy of Human Diabetic Peripheral Blood CD34+ Cells
por: Tanaka, Rica, et al.
Publicado: (2018)

CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
por: Kather, Jakob Nikolas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nrs1l1huuukg756bck46k5903h